Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds
April 25, 2024 08:00 ET
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (CSE: MESC) ("Lophos" or the "Company") proudly announces a milestone accomplishment from its subsidiary, Lophos...
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy
April 17, 2024 08:00 ET
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC) is delighted to announce the successful receipt of building occupancy for...
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership
April 15, 2024 08:00 ET
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. ("ThreeD"), a publicly traded Canadian-based venture capital firm focused on opportunistic investments in...
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan
March 28, 2024 18:43 ET
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (CSE: MESC) ("Lophos" or the "Company") is pleased to announce all matters presented for approval at the annual...
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy
March 05, 2024 07:55 ET
|
Lophos Holdings Inc.
NAPANEE, Ontario, March 05, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos" or the "Company") (CSE:MESC) is pleased to announce its subsidiary, Lophos Pharmaceuticals Corp., has selected...
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting
February 28, 2024 08:00 ET
|
Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to announce its wholly-owned subsidiary, Lophos Pharmaceuticals Corp.,...
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)
February 14, 2024 09:04 ET
|
Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol
February 08, 2024 08:00 ET
|
Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)
January 31, 2024 08:00 ET
|
Lophos Holdings Inc.
NAPANEE, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation
January 23, 2024 10:23 ET
|
Lophos Holdings
NAPANEE, Ontario, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (“Lophos”) (CSE:MESC), a trailblazer in the production of Lophophora williamsii (peyote), proudly announces a significant...